Cargando…

Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls

PURPOSE: Chronic myeloid leukemia (CML) is one of the common hematological malignancies in Nigeria. Cardiac abnormalities are associated with CML irrespective of treatment with tyrosine kinase inhibitors such as imatinib, which is available gratis in Nigeria. OBJECTIVE: To assess the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bamgboje, Abayomi O, Durosinmi, Muheez A, Mene-Afejuku, Tuoyo O, Fagbayimu, Micheal O, Fajobi, Olusola, Balogun, Michael O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857989/ https://www.ncbi.nlm.nih.gov/pubmed/35210781 http://dx.doi.org/10.2147/VHRM.S348744

Ejemplares similares

Ventricular Arrhythmias in Seniors with Heart Failure: Present Dilemmas and Therapeutic Considerations: A Systematic Review
por: Mene-Afejuku, Tuoyo O, et al.
Publicado: (2022)

Echocardiographic Assessment of Left Ventricular Geometric Patterns in Hypertensive Patients in Nigeria
por: Adebayo, Rasaaq A., et al.
Publicado: (2013)

Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test
por: Mene-Afejuku, Tuoyo O, et al.
Publicado: (2017)

Clinical and Echocardiographic Predictors of Arrhythmias Detected With 24-Hour Holter Electrocardiography Among Hypertensive Heart Failure Patients in Nigeria
por: Mene-Afejuku, Tuoyo Omasan, et al.
Publicado: (2017)

Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
por: Oyekunle, Anthony A., et al.
Publicado: (2016)

A Challenging Case of Mechanical Mitral Valve Obstruction
por: Shrestha, Biraj, et al.
Publicado: (2022)

Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
por: Oyekunle, Anthony A., et al.
Publicado: (2015)

A Rare Association of Takotsubo Cardiomyopathy with High-Degree Atrioventricular Block
por: Cativo, Eder Hans, et al.
Publicado: (2017)

Venous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series
por: Mene-Afejuku, Tuoyo O, et al.
Publicado: (2020)

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
por: Ahmed, Ibrahim O., et al.
Publicado: (2021)

Platypnea Orthodeoxia for Those Who do Better Lying Low
por: DeBoer, Rebecca, et al.
Publicado: (2022)

Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations
por: Mene-Afejuku, Tuoyo O., et al.
Publicado: (2019)

Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
por: Langabeer, Stephen E., et al.
Publicado: (2020)

Refractory Heart Failure of Unknown Etiology May Be Cardiac Amyloid If Preceded by Hereditary Neurological Symptoms
por: Mene-Afejuku, Tuoyo 0, et al.
Publicado: (2020)

Cardiac Amyloidosis: A Diagnostic Dilemma and the Role of a Novel Electrocardiogram Criterion
por: Hanif, Muhammad Asad, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura possibly triggered by Graves’ disease
por: Chitnis, Saurabh D, et al.
Publicado: (2017)

Rare Association of Takotsubo Cardiomyopathy with Right Bundle Branch Block in the Dual Setting of Asthma Exacerbation and Psychiatric Illness
por: Kansara, Tikal, et al.
Publicado: (2020)

The Impact of Cocaine Use and the Obesity Paradox in Patients With Heart Failure With Reduced Ejection Fraction Due to Non-ischemic Cardiomyopathy
por: Akinlonu, Adedoyin A, et al.
Publicado: (2023)

Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria
por: Adebayo, Rasaaq A, et al.
Publicado: (2014)

D-Shaped Left Ventricle, Anatomic, and Physiologic Implications
por: Cativo Calderon, Eder Hans, et al.
Publicado: (2017)

Crowned Dens Syndrome Masquerading as Meningitis
por: Bamgboje, Abayomi O, et al.
Publicado: (2021)

CARDIAC INVOLVEMENT IN COVID-19: INSIGHTS FROM A SAFETY NET URBAN HOSPITAL
por: Garcia, Mariana, et al.
Publicado: (2021)

Carotid Intima-Media Thickness: A Surrogate Marker for Cardiovascular Disease in Chronic Kidney Disease Patients
por: Lawal, Olutoyin Morenike, et al.
Publicado: (2019)

Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia
por: Perrotti, Danilo, et al.
Publicado: (2012)

Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C.
Publicado: (2013)

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
por: Tiribelli, Mario, et al.
Publicado: (2019)

Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
por: Ciaffaglione, Valeria, et al.
Publicado: (2022)

Brugada Phenocopy Induced by Recreational Drug Use
por: Akinlonu, Adedoyin, et al.
Publicado: (2018)

Challenges to Care and Medication Adherence of Patients With Chronic Myeloid Leukemia in a Resource Limited Setting: A Qualitative Study
por: Bolarinwa, R A, et al.
Publicado: (2017)

Left Ventricular Aneurysm May Not Manifest as Persistent ST Elevation on Electrocardiogram
por: Ola, Olatunde, et al.
Publicado: (2017)

FULMINANT MYOCARDITIS IN COVID-19 WITH RAPID RECOVERY OF SYSTOLIC FUNCTION
por: Calhoun, Avery, et al.
Publicado: (2021)

The relevance of serum albumin among elderly patients with acute decompensated heart failure
por: Mene-Afejuku, Tuoyo O, et al.
Publicado: (2019)

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
por: Barak, Avital F., et al.
Publicado: (2011)

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
por: Kentsis, Alex, et al.
Publicado: (2012)

When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
por: Laneuville, Pierre
Publicado: (2018)

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
por: García-Gutiérrez, Valentín, et al.
Publicado: (2019)

Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
por: Fernandez, Solène, et al.
Publicado: (2019)

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C., et al.
Publicado: (2020)

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
por: Atallah, Ehab, et al.
Publicado: (2020)

Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia
por: Kim, Yundeok, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4t24rri01f92r7dpj74irc6sgu